BIOMAT Database Logo BIOMAT Database Logo

Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists. 1999

Y N Chen, and S K Sharma, and T M Ramsey, and L Jiang, and M S Martin, and K Baker, and P D Adams, and K W Bair, and W G Kaelin
Novartis Institute for Biomedical Research, Novartis Pharmaceuticals Corporation, 556 Morris Avenue, Summit, NJ 07901, USA.

Recent studies identified a short peptide motif that serves as a docking site for cyclin/cyclin-dependent kinase (cdk) 2 complexes. Peptides containing this motif block the phosphorylation of substrates by cyclin A/cdk2 or cyclin E/cdk2. Here we report that cell membrane-permeable forms of such peptides preferentially induced transformed cells to undergo apoptosis relative to nontransformed cells. Deregulation of E2F family transcription factors is a common event during transformation and was sufficient to sensitize cells to the cyclin/cdk2 inhibitory peptides. These results suggest that deregulation of E2F and inhibition of cdk2 are synthetically lethal and provide a rationale for the development of cdk2 antagonists as antineoplastic agents.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002461 Cell Line, Transformed Eukaryotic cell line obtained in a quiescent or stationary phase which undergoes conversion to a state of unregulated growth in culture, resembling an in vitro tumor. It occurs spontaneously or through interaction with viruses, oncogenes, radiation, or drugs/chemicals. Transformed Cell Line,Cell Lines, Transformed,Transformed Cell Lines
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins

Related Publications

Y N Chen, and S K Sharma, and T M Ramsey, and L Jiang, and M S Martin, and K Baker, and P D Adams, and K W Bair, and W G Kaelin
Selective cyclin-dependent kinase 2/cyclin A antagonists that differ from ATP site inhibitors block tumor growth.
March 2003, Cancer research,
Y N Chen, and S K Sharma, and T M Ramsey, and L Jiang, and M S Martin, and K Baker, and P D Adams, and K W Bair, and W G Kaelin
Selective killing of transformed cells by mechanical stretch.
August 2021, Biomaterials,
Y N Chen, and S K Sharma, and T M Ramsey, and L Jiang, and M S Martin, and K Baker, and P D Adams, and K W Bair, and W G Kaelin
Loss of p27Kip1 from cyclin E/cyclin-dependent kinase (CDK) 2 but not from cyclin D1/CDK4 complexes in cells transformed by polyamine biosynthetic enzymes.
September 2000, Cancer research,
Y N Chen, and S K Sharma, and T M Ramsey, and L Jiang, and M S Martin, and K Baker, and P D Adams, and K W Bair, and W G Kaelin
Loss of cell cycle control by deregulation of cyclin-dependent kinase 2 kinase activity in Evi-1 transformed fibroblasts.
September 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research,
Y N Chen, and S K Sharma, and T M Ramsey, and L Jiang, and M S Martin, and K Baker, and P D Adams, and K W Bair, and W G Kaelin
Selective sensitization of retinoblastoma protein-deficient sarcoma cells to doxorubicin by flavopiridol-mediated inhibition of cyclin-dependent kinase 2 kinase activity.
March 2001, Cancer research,
Y N Chen, and S K Sharma, and T M Ramsey, and L Jiang, and M S Martin, and K Baker, and P D Adams, and K W Bair, and W G Kaelin
Selective killing of transformed baby hamster kidney (BHK) cells.
December 1975, Proceedings of the National Academy of Sciences of the United States of America,
Y N Chen, and S K Sharma, and T M Ramsey, and L Jiang, and M S Martin, and K Baker, and P D Adams, and K W Bair, and W G Kaelin
Discovery of Selective Tertiary Amide Inhibitors of Cyclin-Dependent Kinase 2 (CDK2).
September 2023, ACS medicinal chemistry letters,
Y N Chen, and S K Sharma, and T M Ramsey, and L Jiang, and M S Martin, and K Baker, and P D Adams, and K W Bair, and W G Kaelin
Selective killing of mitogen-induced transformed cells by quinine sulfate in vitro.
January 1978, International archives of allergy and applied immunology,
Y N Chen, and S K Sharma, and T M Ramsey, and L Jiang, and M S Martin, and K Baker, and P D Adams, and K W Bair, and W G Kaelin
Stoichiometry of cyclin A-cyclin-dependent kinase 2 inhibition by p21Cip1/Waf1.
November 2000, Biochemistry,
Y N Chen, and S K Sharma, and T M Ramsey, and L Jiang, and M S Martin, and K Baker, and P D Adams, and K W Bair, and W G Kaelin
Regulation of cyclin-dependent kinase 2 activity by ceramide.
December 2000, Experimental cell research,
Copied contents to your clipboard!